Vi­a­tris leans in on brand drug port­fo­lio for fu­ture growth

Vi­a­tris, the bio­phar­ma formed by the merg­er of gener­ic gi­ants My­lan and Pfiz­er’s Up­john, is lean­ing in­to its brand­ed prod­ucts. Its growth strat­e­gy in­cludes dou­bling …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER